Heghine Khachatryan: Advancing Health Equity in Hemophilia Care – From Resolution to Real Impact
Heghine Khachatryan, Editor-in-Chief of Hemostasis Today, Head of Hemophilia and Thrombosis Center at Yeolyan Hematology and Oncology Center, shared World Federation of Hemophilia‘s post on LinkedIn:
“Advancing Equity in Hemostasis: From Resolution to Real Impact
The recent initiative highlighted by the World Federation of Hemophilia marks a pivotal moment in global health policy.
The proposed World Health Assembly Resolution on — ‘Global Action to Advance Health Equity for People with Hemophilia and Other Bleeding Disorders’ — is not merely a declaration.
It is a structural commitment to transforming care systems worldwide.
As a clinician and policy advocate working in hemostasis, I see three critical dimensions of this resolution:
- Recognition of Unmet Diagnostic Gaps
Across many regions, bleeding disorders remain underdiagnosed—particularly in women and in mild phenotypes. Strengthening laboratory infrastructure and standardization is no longer optional; it is foundational.
- Equity in Access to Treatment
From factor replacement to innovative therapies (including non-factor treatments), disparities in access continue to define patient outcomes. This resolution reinforces the need for sustainable, nationally integrated treatment strategies.
- Systems-Level Implementation
The true value of this resolution lies in its translation into national policies-registries, clinical pathways, reimbursement systems, and workforce training.
Armenia is proud to contribute to this global movement-demonstrating how coordinated clinical expertise, policy engagement, and international collaboration can shape meaningful progress.
This is not just about hemophilia.
It is about redefining health equity in rare and inherited disorders.
The next step is clear:
From advocacy to implementation to measurable patient outcomes.”
Quoting World Federation of Hemophilia‘s post:
“A new resource to support global advocacy for hemophilia and other inherited Bleeding Disorders is now available.
Our new webpage brings together everything you need to understand the World Health Assembly (WHA) resolution on Global Action to Advance Health Equity for People with Hemophilia and Other Bleeding Disorders, led by Armenia with support from twelve co-sponsor WHO Member States.
The new webpage includes background information, key recommendations, and ways organizations can support the WFH’s Global Call for Health Equity for Bleeding Disorders in calling for adoption of this milestone resolution.
Explore the page and learn how this initiative can help drive progress for our community worldwide.”
Stay updated with Hemostasis Today.
-
Aug 14, 2026, 23:18Claire Hills: New Paper on Immune Surveillance and Immune Evasion of Senescent Cells
-
Aug 14, 2026, 23:16Are We Overlooking What Matters Most to Women with Von Willebrand Disease? – RPTH Journal
-
Aug 14, 2026, 23:15Markus Müller: A New Base Editing Approach Targeting PCSK9 to Lower Cholesterol Levels
-
Aug 14, 2026, 23:14Chokri Ben Lamine: Avatrombopag in Hematology – Dosing and Monitoring
-
Aug 14, 2026, 23:13Bianca Rocca: PRECISE-DAPT Score Identifies Bleeding Risk After CABG in Patients With POAF
-
Aug 14, 2026, 19:04Ravi Kumar: Why Lupus Anticoagulant Predicts Clots, Not Bleeding
-
Aug 14, 2026, 18:53Veli Bakalov: The Number Every Hematologist Should Know in Polycythemia Vera
-
Aug 14, 2026, 18:41Marta Velia Antonini: Can Nitric Oxide Protect the ECMO Circuit Without Systemic Anticoagulation?
-
Aug 14, 2026, 18:30Irina Gontschar: What the Epkinly FDA Review Teaches Us About Sponsor Oversight